VICTORIA, British Columbia, Feb. 14, 2018 (GLOBE NEWSWIRE) Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) ( Emerald or the “Company”) has closed its prospectus sale (the “Offering”) to a single Canadian institutional accredited investor (the “Investor”) announced on February 8, 2018. Pursuant to the Offering, the Company has issued 3,000,000 units (the “Units”) at a price per Unit of $6.00 for gross proceeds of $18,000,000. Each Unit consists of one common share of the Company and one common share purchase warrant
http://bit.ly/2Bu9zl3
No comments:
Post a Comment